贝塔-上腺素受体亚型对成年大鼠心室肌细胞的亡有不同的影响
1Department of Anesthesiology, Health Science Center at Brooklyn, State University of New York, USA.
Circulation
|July 19, 2000
概括
β-1 上腺素受体 (ARs) 在心脏细胞中介导甲醇胺诱导的亡,而β-2 上腺素受体起到最小的作用. 这项研究区分了β-1和β-2AR亚型在心脏细胞死亡信号传递中的作用.
科学领域:
- 心脏病学 心脏病学
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 甲基胺诱导的亡是心脏细胞死亡的一个关键过程.
- β-上腺体信号通路参与调解这种亡.
- 在这个过程中,β-1和β-2上腺素受体 (AR) 亚型的不同作用尚未完全理解.
研究的目的:
- 为了研究β-1和β-2上腺素受体 (AR) 亚型在成年大鼠室内肌细胞的 катехоламин诱导的亡中的不同作用.
- 阐明参与β-AR介导心脏亡的特定信号通路.
主要方法:
- 成年大鼠心室肌细胞被单独用诺阿皮内林 (NE) 或与β-1选择性对抗剂阿提诺洛 (AT) 结合治疗.
- 使用TUNEL染色,Annexin V染色,DNA梯级和caspase活性试验来评估亡.
- 使用β-1/β-2 (异二醇) 和β-2选择性 (阿尔布特醇) 激动剂建立了亡的剂量反应曲线.
- 分析了β-2选择性对抗剂ICI 118551的影响以及对BCL-2/Bax比率的影响.
主要成果:
- 贝塔-1选择性对抗剂阿提诺洛尔取消了上腺素诱导的亡,这表明贝塔-1ARs的关键作用.
- 与非选择性激动剂 (异二醇) 和上腺素相比,Beta-2选择性激动剂 (阿尔布醇) 诱导的亡显著较少.
- 选择性β-2 AR对抗剂ICI 118551没有降低亡,进一步支持β-2 ARs的最小作用.
- 阿提诺洛尔逆转了Bcl-2与Bax比率中的β-上腺素信号诱导的变化.
结论:
- β-1上腺素受体 (ARs) 选择性地负责在成年大鼠心室肌细胞中调解类甲基胺诱导的亡信号.
- β-2 ARs在这个亡过程中起到很小或很小的作用.
- 准β-1AR可能是控制心脏亡的关键策略.
相关概念视频
Adrenergic Receptors (Adrenoceptors): Classification
Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
Adrenergic Receptors: ɑ Subtype
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenergic Receptors: β Subtype
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Adrenergic Antagonists: Chemistry and Classification of β-Receptor Blockers
β-adrenergic antagonists, or β-blockers, modulate the sympathetic nervous system by targeting β-adrenoceptors and inhibiting catecholamine-mediated sympathetic responses. β-blockers differ in their adrenoceptor subtype affinity, lipophilicity, and α-blocking capabilities. The history of β-blocker development began with the prototype, dichloroisoprenaline, which exhibited partial agonist activity. As a result, propranolol was developed as a pure antagonist but nonselective agent, paving the way...
Adrenergic Antagonists: ɑ and β-Receptor Blockers
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is clinically...
Sympathetic Signaling
Sympathetic signaling, a vital part of the autonomic nervous system, plays a crucial role in mobilizing the body's resources in response to stress or emergencies. It involves the transmission of nerve impulses from sympathetic preganglionic fibers to postganglionic fibers. This results in the release of specific neurotransmitters and activation of adrenergic receptors.
Sympathetic preganglionic fibers release the neurotransmitter acetylcholine (ACh) onto the ganglionic neurons in the...
Sympathetic preganglionic fibers release the neurotransmitter acetylcholine (ACh) onto the ganglionic neurons in the...


